20 17 Evaluation of the World Omega 3 Biotechnology Contribution Award
The founder of Outlook Life participated in the evaluation of the World Omega 3 Biotechnology Contribution Award.
20 17 Industry Information Oriental Network 2017-07-1815: 39
On July 1 1 day, local time in the United States, the jury of "World Omega 3 Biotechnology Contribution Award" was held in Boston University. The meeting was presided over by Luo, director of "Love Omega 3 Fund Management Committee" and chairman of Shanghai Outlook Group. 1 1 judges from China, the United States, Canada, Britain, Sweden, Italy and Greece attended the meeting.
The "World Omega 3 Biotechnology Contribution Award" was jointly established by China Zengai Public Welfare Foundation and many domestic enterprises, 20 15. It aims to promote the in-depth development of lipid nutrition medical research in the world and encourage more scientists to reveal the mystery of ω-3 fatty acids and human health. The prize is awarded every two years with a prize of $654.38 million. The jury is composed of 1 1 world famous lipid scientists. The first prize was awarded in Shanghai, China on 20 16. The winner was Professor Kang from Harvard University.
Richard p., president-designate of the international society for fatty acid and lipid research. Professor Bazinet thinks: "Omega-3 is an indispensable fatty acid for human body. Since 1972 Professor Delberg of the University of Copenhagen in Denmark discovered that it has a great influence on heart disease, more and more studies have revealed that it is closely related to chronic diseases such as cardiovascular disease, cancer, diabetes, stroke and inflammation, as well as human fertility and aging. "
Dr Simopoulos, chairman of the jury and president of the World Society for Nutritional Genomics, said: "At the World Cardiology Congress held in California in March this year, Omega 3 was recommended for the prevention and treatment of cardiovascular diseases. On April 1 1, the American Heart Association published an article again in the famous journal Circulation: Omega 3 supplements are suitable for patients with diabetes and pre-diabetes, as well as high-risk patients with cardiovascular disease, stroke, heart failure and atrial fibrillation. "
Some judges include Professor Kang (first from the left), Chairman of the International Omega 3 Society, Director of the Omega 3 Management Committee, Luo (second from the right), Chairman of the Jury, and Doctor (fourth from the right), Chairman of the World Society of Nutritional Genomics.
Dr. Zhao Feng, Deputy Director of Fatty Acid Research Center of School of Nutrition and Health, Qingdao University, spoke at the meeting: Popularizing omega -3 and health knowledge in China can benefit one fifth of the world's population. We hope to strengthen cooperation with our counterparts in other countries and carry out in-depth basic scientific research on fatty acids and health.
Dr. Li Duo, a member of the jury, nutrition consultant of the World Health Organization and president of the Asia-Pacific Nutrition Society, pointed out: "Today, the China government attaches great importance to the health of the whole people, and" Healthy China "is a national strategy. Therefore, this award established by the Chinese people will greatly promote scientific research in the field of fatty acids in China and even in the world. "
Luo, director of the Omega 3 Fund Management Committee and chairman of Shanghai Prospect Group, said: "The Omega 3 Biotechnology Contribution Award is a worldwide scientific and technological award established by the people of China. The jury members come from many countries, and the winners are not limited to China, so this jury meeting was decided to be held in Boston, USA. The second prize will be announced and awarded at the 13 World Fatty Acid Research Conference in Las Vegas, USA in May next year. "
The east. com